Trial Profile
Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Immunological disorders
- Focus Pharmacodynamics
- Acronyms FAPESP
- 18 Sep 2014 New trial record